Does DURVALUMAB Cause Immune-mediated thyroiditis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Immune-mediated thyroiditis have been filed in association with DURVALUMAB (IMFINZI). This represents 0.0% of all adverse event reports for DURVALUMAB.
5
Reports of Immune-mediated thyroiditis with DURVALUMAB
0.0%
of all DURVALUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Immune-mediated thyroiditis From DURVALUMAB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Immune-mediated thyroiditis Listed in the Official Label?
Yes, Immune-mediated thyroiditis is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Immune-mediated thyroiditis?
PEMBROLIZUMAB (189)
NIVOLUMAB (156)
IPILIMUMAB (109)
CARBOPLATIN (50)
PACLITAXEL (34)
LENVATINIB (29)
CYCLOPHOSPHAMIDE (13)
PEMETREXED (11)
ACETAMINOPHEN (10)
ASPIRIN (10)
Which DURVALUMAB Alternatives Have Lower Immune-mediated thyroiditis Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE